Serum lipid profiles and cancer risk in the context of obesity: Four meta-analyses

Journal of Cancer Epidemiology

Volumn 2013, Issue , 2013, Pages

  Melvin, Jennifer C ^a,b   Holmberg, Lars ^a,b,c   Rohrmann, Sabine ^d   Loda, Massimo ^a,e,f,g   Van Hemelrijck, Mieke ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e DANA FARBER CANCER INSTITUTE   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPID; TRIACYLGLYCEROL;

CANCER RISK; CHOLESTEROL BLOOD LEVEL; HUMAN; LIFESTYLE; LIFESTYLE MODIFICATION; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; OBESITY; PRIORITY JOURNAL; REVIEW; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84874625067     PISSN: 16878558     EISSN: 16878566     Source Type: Journal    
DOI: 10.1155/2013/823849     Document Type: Review

References (89)

1. Grundy S. M., Metabolic complications of obesity. Endocrine 2000 13 2 155 165 2-s2.0-0033758124
2. Jee S. H., Kim H. J., Lee J., Obesity, insulin resistance and cancer risk. Yonsei Medical Journal 2005 46 4 449 455 2-s2.0-24644436798 (Pubitemid 41283053)
3. Jung R. T., Obesity as a disease. British Medical Bulletin 1997 53 2 307 321 2-s2.0-0030948614 (Pubitemid 27272042)
4. Pender J. R., Pories W. J., Epidemiology of obesity in the United States. Gastroenterology Clinics of North America 2005 34 1 1 7 2-s2.0-16844364898 10.1016/j.gtc.2004.12.010 (Pubitemid 40488727)
5. Lawrence V. J., Kopelman P. G., Medical consequences of obesity. Clinics in Dermatology 2004 22 4 296 302 2-s2.0-4744348346 10.1016/j.clindermatol.2004. 01.012 (Pubitemid 39314614)
6. Vainio H., Kaaks R., Bianchini F., Weight control and physical activity in cancer prevention: international evaluation of the evidence. European Journal of Cancer Prevention 2002 11 2 S94 S100 2-s2.0-0036701556 (Pubitemid 35265868)
7. Renehan A. G., Tyson M., Egger M., Heller R. F., Zwahlen M., Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. The Lancet 2008 371 9612 569 578 2-s2.0-38949108241 10.1016/S0140-6736(08)60269-X (Pubitemid 351232031)
8. Malnick S. D. H., Knobler H., The medical complications of obesity. QJM 2006 99 9 565 579 2-s2.0-33749616411 10.1093/qjmed/hcl085 (Pubitemid 44540533)
9. Arslan A. A., Helzlsouer K. J., Kooperberg C., Shu X.-O., Steplowski E., Fuchs C. S., Gross M. D., Jacobs E. J., LaCroix A. Z., Petersen G. M., Stolzenberg-Solomon R. Z., Zheng W., Albanes D., Amundadottir L., Bamlet W. R., Barricarte A., Bingham S. A., Boeing H., Boutron-Ruault M.-C., Buring J. E., Chanock S. J., Clipp S., Gaziano J. M., Giovannucci E. L., Hankinson S. E., Hartge P., Hoover R. N., Hunter D. J., Hutchinson A., Jacobs K. B., Kraft P., Lynch S. M., Manjer J., Manson J. E., McTiernan A., McWilliams R. R., Mendelsohn J. B., Michaud D. S., Palli D., Rohan T. E., Slimani N., Thomas G., Tjønneland A., Tobias G. S., Trichopoulos D., Virtamo J., Wolpin B. M., Yu K., Zeleniuch-Jacquotte A., Patel A. V., Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium (PanScan). Archives of Internal Medicine 2010 170 9 791 802 10.1001/archinternmed.2010.63
10. Van Itallie T. B., Obesity: adverse effects on health and longevity. American Journal of Clinical Nutrition 1979 32 12 2723 2733 2-s2.0-0018616780 (Pubitemid 10171120)
11. Vrieling A., Buck K., Kaaks R., Chang-Claude J., Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis. Breast Cancer Research and Treatment 2010 123 3 641 649 2-s2.0-79952116037
12. Saunders D., Seidel D., Allison M., Lyratzopoulos G., Systematic review: the association between obesity and hepatocellular carcinoma-epidemiological evidence. Alimentary Pharmacology and Therapeutics 2010 31 10 1051 1063 2-s2.0-77951222429 10.1111/j.1365-2036.2010.04271.x
13. Fuemmeler B. F., Pendzich M. K., Tercyak K. P., Weight, dietary behavior, and physical activity in childhood and adolescence: implications for adult cancer risk. Obesity Facts 2009 2 3 179 186 2-s2.0-68949124851 10.1159/000220605
14. Harriss D. J., Atkinson G., George K., Tim Cable N., Reilly T., Haboubi N., Zwahlen M., Egger M., Renehan A. G., Lifestyle factors and colorectal cancer risk (1): systematic review and meta-analysis of associations with body mass index. Colorectal Disease 2009 11 6 547 563 2-s2.0-67749122332 10.1111/j.1463-1318.2009.01766.x
15. Dai Z., Xu Y. C., Niu L., Obesity and colorectal cancer risk: a meta-analysis of cohort studies. World Journal of Gastroenterology 2007 13 31 4199 4206 2-s2.0-34548515276 (Pubitemid 47377159)
16. Larsson S. C., Wolk A., Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. American Journal of Clinical Nutrition 2007 86 3 556 565 2-s2.0-34548787820 (Pubitemid 47435820)
17. Qian Y., Fan J. G., Obesity, fatty liver and liver cancer. Hepatobiliary & Pancreatic Diseases International 2005 4 2 173 177 2-s2.0-20344402794 (Pubitemid 40790160)
18. Leroith D., Novosyadlyy R., Gallagher E. J., Lann D., Vljayakumar A., Yakar S., Leroith D., Obesity and type 2 diabetes are associated with an increased risk of developing cancer and a worse prognosis; epidemiological and mechanistic evidence. Experimental and Clinical Endocrinology and Diabetes 2008 116 1 S4 S6 2-s2.0-54549094827 10.1055/s-2008-1081488
19. Khandekar M. J., Cohen P., Spiegelman B. M., Molecular mechanisms of cancer development in obesity. Nature Reviews Cancer 2011 11 12 886 895 10.1038/nrc3174
20. Meikle P. J., Christopher M. J., Lipidomics is providing new insight into the metabolic syndrome and its sequelae. Current Opinion in Lipidology 2011 22 3 210 215 2-s2.0-79957921347 10.1097/MOL.0b013e3283453dbe
21. Tanasescu M., Leitzmann M. F., Rimm E. B., Hu F. B., Physical activity in relation to cardiovascular disease and total mortality among men with type 2 diabetes. Circulation 2003 107 19 2435 2439 2-s2.0-0037986316 10.1161/01.CIR.0000066906.11109.1F (Pubitemid 36605225)
22. Manini T. M., Everhart J. E., Patel K. V., Schoeller D. A., Colbert L. H., Visser M., Tylavsky F., Bauer D. C., Goodpaster B. H., Harris T. B., Daily activity energy expenditure and mortality among older adults. Journal of the American Medical Association 2006 296 2 171 179 2-s2.0-33745875031 10.1001/jama.296.2.171 (Pubitemid 44050370)
23. Gregg E. W., Cauley J. A., Stone K., Thompson T. J., Bauer D. C., Cummings S. R., Ensrud K. E., Relationship of changes in physical activity and mortality among older women. Journal of the American Medical Association 2003 289 18 2379 2386 2-s2.0-0038655478 10.1001/jama.289.18.2379 (Pubitemid 37430170)
24. Elmer P. J., Obarzanek E., Vollmer W. M., Simons-Morton D., Stevens V. J., Young D. R., Lin P. H., Champagne C., Harsha D. W., Svetkey L. P., Ard J., Brantley P. J., Proschan M. A., Erlinger T. P., Appel L. J., Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-Month results of a randomized trial. Annals of Internal Medicine 2006 144 7 485 495 2-s2.0-33645800760 (Pubitemid 46780671)
25. Meyerhardt J. A., Giovannucci E. L., Ogino S., Kirkner G. J., Chan A. T., Willett W., Fuchs C. S., Physical activity and male colorectal cancer survival. Archives of Internal Medicine 2009 169 22 2102 2108 2-s2.0-73149113066 10.1001/archinternmed.2009.412
26. McTiernan A., Irwin M., VonGruenigen V., Weight, physical activity, diet, and prognosis in breast and gynecologic cancers. Journal of Clinical Oncology 2010 28 26 4074 4080 2-s2.0-77956898900 10.1200/JCO.2010.27.9752
27. Ligibel J. A., Giobbie-Hurder A., Olenczuk D., Campbell N., Salinardi T., Winer E. P., Mantzoros C. S., Impact of a mixed strength and endurance exercise intervention on levels of adiponectin, high molecular weight adiponectin and leptin in breast cancer survivors. Cancer Causes & Control 2009 20 8 1523 1528 2-s2.0-77953648429 10.1007/s10552-009-9358-3
28. Ligibel J. A., Campbell N., Partridge A., Chen W. Y., Salinardi T., Chen H., Adloff K., Keshaviah A., Winer E. P., Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors. Journal of Clinical Oncology 2008 26 6 907 912 2-s2.0-39749084232 10.1200/JCO.2007.12.7357 (Pubitemid 351398083)
29. Gonyeau M. J., Yuen D. W., A clinical review of statins and cancer: helpful or harmful? Pharmacotherapy 2010 30 2 177 194 2-s2.0-75849124050 10.1592/phco.30.2.177
30. Emberson J. R., Kearney P. M., Blackwell L., Newman C., Reith C., Bhala N., Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy. PloS One 2012 7 1 e29849
31. Mooradian A. D., Haas M. J., Wehmeier K. R., Wong N. C. W., Obesity-related changes in high-density lipoprotein metabolism. Obesity 2008 16 6 1152 1160 2-s2.0-44449123689 10.1038/oby.2008.202 (Pubitemid 351770500)
32. Jafri H., Alsheikh-Ali A. A., Karas R. H., Baseline and On-treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-altering therapy. Journal of the American College of Cardiology 2010 55 25 2846 2854 2-s2.0-77953318994 10.1016/j.jacc.2009.12.069
33. Kok D. E., van Roermund J. G., Aben K. K., den Heijer M., Swinkels D. W., Kampman E., Blood lipid levels and prostate cancer risk, a cohort study. Prostate Cancer and Prostatic Diseases 2011 14 4 340 345
34. McAuley D., Conventional Units-International Units. 1993, http://www.globalrph.com/conv-si.htm
35. Jungner I., Walldius G., Holme I., Kolar W., Steiner E., Apolipoprotein B and A-I in relation to serum cholesterol and triglycerides in 43 000 Swedish males and females. International Journal of Clinical & Laboratory Research 1992 21 2-4 247 255 2-s2.0-0026437076 10.1007/BF02591655
36. Shlipak M. G., Katz R., Kestenbaum B., Fried L. F., Newman A. B., Siscovick D. S., Stevens L., Sarnak M. J., Rate of kidney function decline in older adults: a comparison using creatinine and cystatin C. American Journal of Nephrology 2009 30 3 171 178 2-s2.0-63649159890 10.1159/000212381
37. Millan J., Pinto X., Munoz A., Zuniga M., Rubies-Prat J., Pallardo L. F., Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention. Vascular Health and Risk Management 2009 5 757 765
38. Cleeman J. I., Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Journal of the American Medical Association 2001 285 19 2486 2497 2-s2.0-0035897696 (Pubitemid 32433843)
39. Ahn J., Lim U., Weinstein S. J., Schatzkin A., Hayes R. B., Virtamo J., Albanes D., Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer. Cancer Epidemiology Biomarkers and Prevention 2009 18 11 2814 2821 2-s2.0-72749091502 10.1158/1055-9965.EPI-08-1248
40. Deeks J. J., Altman D. G., Bradburn M. J., Egger M., Smith G. D., Altman D. G., Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta-Analysis. Systematic Reviews in Health Care: Meta-Analysis in Context 2008 Chapter 15 London, UK BMJ Publishing 10.1002/9780470693926.ch15
41. Swinnen J. V., Heemers H., Van De Sande T., De Schrijver E., Brusselmans K., Heyns W., Verhoeven G., Androgens, lipogenesis and prostate cancer. Journal of Steroid Biochemistry and Molecular Biology 2004 92 4 273 279 2-s2.0-12344287240 10.1016/j.jsbmb.2004.10.013 (Pubitemid 40128248)
42. Mehta N., Hordines J., Volpe C., Doerr R., Cohen S. A., Cellular effects of hypercholesterolemia in modulation of cancer growth and metastasis: a review of the evidence. Surgical Oncology 1997 6 3 179 185 2-s2.0-0031424597 10.1016/S0960-7404(97)00027-3 (Pubitemid 28119142)
43. Arliss R. M., Biermann C. A., Do soy isoflavones lower cholesterol, inhibit atherosclerosis, and play a role in cancer prevention? Holistic Nursing Practice 2002 16 5 40 48 2-s2.0-0036778413
44. Mutoh M., Akasu T., Takahashi M., Niho N., Yoshida T., Sugimura T., Wakabayashi K., Possible involvement of hyperlipidemia in increasing risk of colorectal tumor development in human familial adenomatous polyposis. Japanese Journal of Clinical Oncology 2006 36 3 166 171 2-s2.0-33645866760 10.1093/jjco/hyi233
45. Flavin R., Zadra G., Loda M., Metabolic alterations and targeted therapies in prostate cancer. Journal of Pathology 2011 223 2 283 294 2-s2.0-78649998496 10.1002/path.2809
46. Micheau O., Solary E., Hammann A., Martin F., Dimanche-Boitrel M. T., Sensitization of cancer cells treated with cytotoxic drugs to fas- mediated cytotoxicity. Journal of the National Cancer Institute 1997 89 11 783 789 2-s2.0-0030966954 (Pubitemid 27242279)
47. Migita T., Ruiz S., Fornari A., Loda M., Fiorentino M., Priolo C., Zadra G., Inazuka F., Grisanzio C., Palescandolo E., Shin E., Fiore C., Xie W., Kung A. L., Febbo P. G., Subramanian A., Mucci L., Ma J., Signoretti S., Stampfer M., Hahn W. C., Finn S., Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer. Journal of the National Cancer Institute 2009 101 7 519 532 2-s2.0-63649099458 10.1093/jnci/djp030
48. Rossi S., Graner E., Febbo P., Weinstein L., Bhattacharya N., Onody T., Bubley G., Balk S., Loda M., Fatty acid synthase expression defines distinct molecular signatures in prostate cancer. Molecular Cancer Research 2003 1 10 707 715 2-s2.0-0042429210 (Pubitemid 37025589)
49. Kimura Y., Sumiyoshi M., High-fat, high-sucrose, and high-cholesterol diets accelerate tumor growth and metastasis in tumor-bearing mice. Nutrition and Cancer 2007 59 2 207 216 2-s2.0-36849036395 (Pubitemid 350230739)
50. Brown M., Hart C., Tawadros T., Ramani V., Sangar V., Lau M., The differential effects of statins on the metastatic behaviour of prostate cancer. British Journal of Cancer 2012 106 10 1689 1696
51. Yasuda Y., Shimizu M., Shirakami Y., Sakai H., Kubota M., Hata K., Hirose Y., Tsurumi H., Tanaka T., Moriwaki H., Pitavastatin inhibits azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice. Cancer Science 2010 101 7 1701 1707 2-s2.0-77954645899 10.1111/j.1349-7006.2010.01579.x
52. Jacobs E. J., Gapstur S. M., Cholesterol and cancer: answers and new questions. Cancer Epidemiology Biomarkers and Prevention 2009 18 11 2805 2806 2-s2.0-72749113327 10.1158/1055-9965.EPI-09-1027
53. Calabresi L., Rossoni G., Gomaraschi M., Sisto F., Berti F., Franceschini G., High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor- α content and enhancing prostaglandin release. Circulation Research 2003 92 3 330 337 2-s2.0-0037458924 10.1161/01.RES.0000054201.60308.1A (Pubitemid 36258556)
54. Pichard C., Plu-Bureau G., Neves-e Castro M., Gompel A., Insulin resistance, obesity and breast cancer risk. Maturitas 2008 60 1 19 30 2-s2.0-45849102031 10.1016/j.maturitas.2008.03.002
55. Adderley-Kelly B., Williams-Stephens E., The relationship between obesity and breast cancer. The ABNF Journal 2003 14 3 61 65 2-s2.0-0042468184
56. Barnett J. B., The relationship between obesity and breast cancer risk and mortality. Nutrition Reviews 2003 61 2 73 76 2-s2.0-0037669216 10.1301/nr.2003.febr.73-76 (Pubitemid 37259968)
57. Kaaks R., Lukanova A., Kurzer M. S., Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiology Biomarkers and Prevention 2002 11 12 1531 1543 2-s2.0-0036907571 (Pubitemid 36020003)
58. Bracci P. M., Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms. Molecular Carcinogenesis 2012 51 1 53 63 10.1002/mc.20778
59. Jiao L., Berrington de Gonzalez A., Hartge P., Pfeiffer R. M., Park Y., Freedman D. M., Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts. Cancer Causes & Control 2010 21 8 1305 1314 10.1007/s10552-010-9558-x
60. De Gonzalez A. B., Sweetland S., Spencer E., A meta-analysis of obesity and the risk of pancreatic cancer. British Journal of Cancer 2003 89 3 519 523 2-s2.0-0041976914 10.1038/sj.bjc.6601140 (Pubitemid 37026437)
61. Moyad M. A., Is obesity a risk factor for prostate cancer, and does it even matter? A hypothesis and different perspective. Urology 2002 59 4 41 50 2-s2.0-0036215299 10.1016/S0090-4295(01)01175-X (Pubitemid 34286430)
62. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Report of A WHO/IDF Consulation 2006 Geneva, Switzerland World Health Organisation
63. Inoue M., Noda M., Kurahashi N., Iwasaki M., Sasazuki S., Iso H., Tsugane S., Impact of metabolic factors on subsequent cancer risk: results from a large-scale population-based cohort study in Japan. European Journal of Cancer Prevention 2009 18 3 240 247 2-s2.0-68049121746 10.1097/CEJ.0b013e3283240460
64. Iso H., Ikeda A., Inoue M., Sato S., Tsugane S., Serum cholesterol levels in relation to the incidence of cancer: the JPHC study cohorts. International Journal of Cancer 2009 125 11 2679 2686 2-s2.0-70350736112 10.1002/ijc.24668
65. Kitahara C. M., De González A. B., Freedman N. D., Huxley R., Mok Y., Jee S. H., Samet J. M., Total cholesterol and cancer risk in a large prospective study in Korea. Journal of Clinical Oncology 2011 29 12 1592 1598 2-s2.0-79955040537 10.1200/JCO.2010.31.5200
66. Mainous A. G. III, Wells B. J., Koopman R. J., Everett C. J., Gill J. M., Iron, lipids, and risk of cancer in the Framingham offspring cohort. American Journal of Epidemiology 2005 161 12 1115 1122 2-s2.0-20544438985 10.1093/aje/kwi131 (Pubitemid 40847339)
67. Melvin J. C., Seth D., Holmberg L., Lipid profiles and risk of breast and ovarian cancer in the Swedish AMORIS study. Cancer Epidemiology, Biomarkers & Prevention 2012 21 8 1381 1384 10.1158/1055-9965.EPI-12-0188
68. Chang S. J., Hou M. F., Tsai S. M., Wu S. H., Hou L. A., Ma H., Shann T. Y., Wu S. H., Tsai L. Y., The association between lipid profiles and breast cancer among Taiwanese women. Clinical Chemistry and Laboratory Medicine 2007 45 9 1219 1223 2-s2.0-34548577115 10.1515/CCLM.2007.263 (Pubitemid 47396275)
69. Furberg A. S., Veierød M. B., Wilsgaard T., Berstein L., Thune I., Serum high density lipoprotein cholesterol, metabolic profile, and breast cancer risk. Journal of the National Cancer Institute 2004 96 15 1152 1160 2-s2.0-3543092614 (Pubitemid 39207051)
70. Ha M., Sung J., Song Y. M., Serum total cholesterol and the risk of breast cancer in postmenopausal Korean women. Cancer Causes & Control 2009 20 7 1055 1060 10.1007/s10552-009-9301-7
71. Hayashi N., Matsushima M., Yamamoto T., Sasaki H., Takahashi H., Egawa S., The impact of hypertriglyceridemia on prostate cancer development in patients aged ≥60 years. BJU International 2012 109 4 515 519 2-s2.0-79961102334 10.1111/j.1464-410X.2011.10358.x
72. Kaye J. A., Meier C. R., Walker A. M., Jick H., Statin use, hyperlipidaemia, and the risk of breast cancer. British Journal of Cancer 2002 86 9 1436 1439 2-s2.0-0037029714 10.1038/sj.bjc.6600267 (Pubitemid 34548066)
73. Kim Y., Park S. K., Han W., Kim D. H., Hong Y. C., Ha E. H., Ahn S. H., Noh D. Y., Kang D., Yoo K. Y., Serum high-density lipoprotein cholesterol and breast cancer risk by menopausal status, body mass index, and hormonal receptor in Korea. Cancer Epidemiology Biomarkers & Prevention 2009 18 2 508 515 2-s2.0-60549099737 10.1158/1055-9965.EPI-08-0133
74. Lindemann K., Vatten L. J., Ellstrøm-Engh M., Eskild A., Serum lipids and endometrial cancer risk: results from the HUNT-II study. International Journal of Cancer 2009 124 12 2938 2941 2-s2.0-65649083344 10.1002/ijc.24285
75. Cust A. E., Kaaks R., Friedenreich C., Bonnet F., Laville M., Tjønneland A., Olsen A., Overvad K., Jakobsen M. U., Chajès V., Clavel-Chapelon F., Boutron-Ruault M. C., Linseisen J., Lukanova A., Boeing H., Pischon T., Trichopoulou A., Christina B., Trichopoulos D., Palli D., Berrino F., Panico S., Tumino R., Sacerdote C., Gram I. T., Lund E., Quirós J. R., Travier N., Martínez-García C., Larrañaga N., Chirlaque M. D., Ardanaz E., Berglund G., Lundin E., Bueno-De-Mesquita H. B., Van Duijnhoven F. J. B., Peeters P. H. M., Bingham S., Khaw K. T., Allen N., Key T., Ferrari P., Rinaldi S., Slimani N., Riboli E., Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocrine-Related Cancer 2007 14 3 755 767 2-s2.0-35948940140 10.1677/ERC-07-0132 (Pubitemid 350074064)
76. Seth D., Garmo H., Wigertz A., Lipid profiles and the risk of endometrial cancer in the Swedish AMORIS study. International Journal of Molecular Epidemiology and Genetics 2012 3 2 122 133
77. Magura L., Blanchard R., Hope B., Beal J. R., Schwartz G. G., Sahmoun A. E., Hypercholesterolemia and prostate cancer: a hospital-based case-control study. Cancer Causes & Control 2008 19 10 1259 1266 10.1007/s10552-008-9197- 7
78. Mondul A. M., Clipp S. L., Helzlsouer K. J., Platz E. A., Association between plasma total cholesterol concentration and incident prostate cancer in the CLUE II cohort. Cancer Causes and Control 2010 21 1 61 68 2-s2.0-74149090520 10.1007/s10552-009-9434-8
79. Mondul A. M., Weinstein S. J., Virtamo J., Albanes D., Serum total and HDL cholesterol and risk of prostate cancer. Cancer Causes & Control 2011 22 11 1545 1552 10.1007/s10552-011-9831-7
80. Platz E. A., Till C., Goodman P. J., Parnes H. L., Figg W. D., Albanes D., Neuhouser M. L., Klein E. A., Thompson I. M., Kristal A. R., Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial. Cancer Epidemiology Biomarkers & Prevention 2009 18 11 2807 2813 2-s2.0-72749105394 10.1158/1055-9965.EPI- 09-0472
81. Van Hemelrijck M., Walldius G., Jungner I., Hammar N., Garmo H., Binda E., Hayday A., Lambe M., Holmberg L., Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS study. Cancer Causes & Control 2011 22 7 1011 1019 2-s2.0-79960262470 10.1007/s10552-011- 9774-z
82. Van Hemelrijck M., Garmo H., Holmberg L., Walldius G., Jungner I., Hammar N., Lambe M., Prostate cancer risk in the Swedish AMORIS study. Cancer 2011 117 10 2086 2095 2-s2.0-79955515915 10.1002/cncr.25758
83. Bravi F., Scotti L., Bosetti C., Talamini R., Negri E., Montella M., Franceschi S., La Vecchia C., Self-reported history of hypercholesterolaemia and gallstones and the risk of prostate cancer. Annals of Oncology 2006 17 6 1014 1017 2-s2.0-33646877217 10.1093/annonc/mdl080 (Pubitemid 43778996)
84. Tsushima M., Nomura A. M. Y., Lee J., Stemmermann G. N., Prospective study of the association of serum triglyceride and glucose with colorectal cancer. Digestive Diseases and Sciences 2005 50 3 499 505 2-s2.0-17444374904 10.1007/s10620-005-2464-5 (Pubitemid 40543738)
85. van Duijnhoven F. J., Bueno-De-Mesquita H. B., Calligaro M., Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition. Gut 2011 60 8 1094 1102 10.1136/gut.2010.225011
86. Chung Y. W., Han D. S., Park Y. K., Son B. K., Paik C. H., Lee H. L., Jeon Y. C., Sohn J. H., Association of obesity, serum glucose and lipids with the risk of advanced colorectal adenoma and cancer: a case-control study in Korea. Digestive and Liver Disease 2006 38 9 668 672 2-s2.0-33748512371 10.1016/j.dld.2006.05.014 (Pubitemid 44356269)
87. Van Hemelrijck M., Garmo H., Hammar N., Jungner I., Walldius G., Lambe M., Holmberg L., The interplay between lipid profiles, glucose, BMI and risk of kidney cancer in the Swedish AMORIS study. International Journal of Cancer 2012 130 9 2118 2128 10.1002/ijc.26212 2-s2.0-79960996099 10.1002/ijc.26212
88. Andreotti G., Chen J., Gao Y.-T., Rashid A., Chang S.-C., Shen M.-C., Wang B.-S., Han T.-Q., Zhang B.-H., Danforth K. N., Althuis M. D., Hsing A. W., Serum lipid levels and the risk of biliary tract cancers and biliary stones: A population-based study in China. International Journal of Cancer 2008 122 10 2322 2329 10.1002/ijc.23307 (Pubitemid 351542338)
89. Asano K., Kubo M., Yonemoto K., Doi Y., Ninomiya T., Tanizaki Y., Arima H., Shirota T., Matsumoto T., Iida M., Kiyohara Y., Impact of serum total cholesterol on the incidence of gastric cancer in a population-based prospective study: the Hisayama study. International Journal of Cancer 2008 122 4 909 914 10.1002/ijc.23191